R2030038 |
Capromorelin |
Capromorelin is an orally active, potent growth hormone secretagogue receptor (G
|
R2030039 |
ASISCHEM D48940 |
|
R2030040 |
Avibactam free acid(NXL-104 free acid) |
Avibactam free acid (NXL-104 free acid) is a covalent, reversible non-β-lactam β
|
R2030041 |
Cefminox Disodium salt (MT-141 Disodium salt) |
Cefminox Disodium salt (MT-141) is a semisynthetic cephamycin, which exhibi
|
R2030042 |
Eltrombopag (SB-497115) |
Eltrombopag (SB-497115) is a thrombopoietin (TPO) receptor agonist developed for
|
R2030043 |
PD0332991 Isethionate |
Palbociclib isethionate is a highly selective inhibitor of CDK4/6 with
|
R2030046 |
Entacapone |
Entacapone is a specific, potent, peripherally acting catechol-O-methyltransfera
|
R2030047 |
Ensartinib;X-396 |
Ensartinib;X-396 is a potent and highly specific ALK tyrosine kinase inhibitor (
|
R2030048 |
Niraparib Tosylate Monohydrate |
Niraparib tosylate (MK-4827 tosylate) is a highly potent and orally bioavailable
|
R2030050 |
Baloxavir marboxil(S-033188) |
Baloxavir marboxil is a small molecule inhibitor of the cap-dependent endonuclea
|
R2030052 |
Maribavir(1263W94; BW1263W94; GW257406X) |
Maribavir is a potent inhibitor of histone phosphorylation catalyzed by wild-typ
|
R2030053 |
Bictegravir (GS-9883) |
Bictegravir is a novel, potent inhibitor of HIV-1 integrase with an IC50 of 7.5
|
R2030054 |
Olmesartan (medoxomil) (CS 866) |
Olmesartan medoxomil is a potent and selective angiotensin AT1 receptor inhibito
|
R2030055 |
Teneligliptin hydrobromide(MP-513 hydrobromide) |
Teneligliptin (MP-513) hydrobromide is a potent chemotype prolylthiazolidine-bas
|
R2030056 |
Alogliptin (SYR-322 free base) |
Alogliptin (SYR-322 free base) is a potent, selective inhibitor of DPP-4 with IC
|
R2030057 |
Aceclofenac |
Aceclofenac is a non-steroidal anti-inflammatory drug (NSAID) analog of Diclofen
|
R2030058 |
ASP3026 |
ASP3026 is a novel and selective inhibitor for ALK (anaplastic lymphoma kinase)
|
R2030059 |
Mutant EGFR inhibitor |
Mutant EGFR inhibitor is a potent and selective mutant EGFR inhibitor extracted
|
R2030060 |
Rociletinib hydrobromide(CO-1686 hydrobromide;AVL-301 hydrobromide;CNX-419 hydrobromide) |
Rociletinib hydrobromide (CO-1686 hydrobromide) is an orally delivered kinase in
|
R2030061 |
JAK3-IN-1 |
JAK3-IN-1 (Compound 9) is a potent, selective and orally active JAK3 inhibitor w
|
R2030062 |
Amcasertib (BBI503) |
Amcasertib is an orally administered investigational agent designed to inhibit c
|
R2030063 |
BACE1-IN-2 |
BACE1-IN-2 is a 1,4-Oxazine β-Secretase 1 (BACE1) inhibitor with an IC50 of 22 n
|
R2030064 |
JNJ-678 (JNJ-53718678) |
JNJ-678 (JNJ-53718678) is a novel fusion protein inhibitor in clinical trials fo
|
R2030065 |
IDO-IN-8 (NLG-1487) |
IDO-IN-8 (NLG-1487) is an indoleamine 2,3-dioxygenase (IDO) inhibitor extracted
|
R2030066 |
GSK2798745 |
GSK2798745 is a first-in-class, highly potent, selective, orally active transien
|